胶州湾放线菌的分离及其抗病原微生物的活性检测(英文)

崔洪霞, 侯竹美, 秦松

崔洪霞, 侯竹美, 秦松. 胶州湾放线菌的分离及其抗病原微生物的活性检测(英文)[J]. 水生生物学报, 2007, 31(5): 649-654.
引用本文: 崔洪霞, 侯竹美, 秦松. 胶州湾放线菌的分离及其抗病原微生物的活性检测(英文)[J]. 水生生物学报, 2007, 31(5): 649-654.
CUI Hong-Xia, HOU Zhu-Mei, QIN Song. ISOLATION OF STRAINS OF ACTINOMYCETES FROM JIAOZHOU BAY AND THEIR ACTIVITIES AGAINST PATHOGENIC MICROORGANISMS[J]. ACTA HYDROBIOLOGICA SINICA, 2007, 31(5): 649-654.
Citation: CUI Hong-Xia, HOU Zhu-Mei, QIN Song. ISOLATION OF STRAINS OF ACTINOMYCETES FROM JIAOZHOU BAY AND THEIR ACTIVITIES AGAINST PATHOGENIC MICROORGANISMS[J]. ACTA HYDROBIOLOGICA SINICA, 2007, 31(5): 649-654.

胶州湾放线菌的分离及其抗病原微生物的活性检测(英文)

基金项目: 

Hi-Tech Research and Development Program of China(2001AA624020)

Key Innovative Project of the Chinese Academy of Science(KZCX3-SW-215)

ISOLATION OF STRAINS OF ACTINOMYCETES FROM JIAOZHOU BAY AND THEIR ACTIVITIES AGAINST PATHOGENIC MICROORGANISMS

  • 摘要: 采用涂布法,从胶州湾海泥样品中分离到224株放线菌菌株,并且从海水样品中分离到32株放线菌菌株。根据形态学特性,菌株被分成了7个组。同时利用杯碟法测定了它们的抗菌活性,其中约7%对金黄色葡萄球菌有活性,11%对八叠球菌有效,10%对大肠杆菌有效,11%对绿脓杆菌有效,2%对白色念珠菌有效,5%对隐球菌有效,6%对绿色产色链霉菌有效和6%对米赫毛霉有效。分离到的22%放线菌对所测定的病原微生物有抗性作用。我们的结果表明胶州湾放线菌能够产生对病原微生物有抗性作用的不同代谢物,这些代谢物可以作为筛选新颖天然产物的独特和丰富的资源。
    Abstract: We isolated 224 actinomycetes strainsfrom sea mud samples and 32 strainsfrom seawater samples of the Jiaozhou Bay, China,by using the spread method1 The isolates were grouped into 7 groups on basis of their morphological characteristics1 Their antimicrobial activities were tested by using the cup-plate method, and the results showed that 7% of the isolates were active against Staphylococcus aureus, 11% against Sarcine lutea, 10% against Escherichia coli, 11% against Bacillus pyocyaneus, 2% against Candida albicans, 5% against Cryptococcus, 6% against Streptomyces viridochromogenes, and 6% against Mucor miehei1 Twenty-two percent of isolates were active against at least one of the test organisms1 Our data suggests that actinomycetesfrom the Jiaozhou Bay, China can produce various active metabolites against pathogenic microorganisms, which provids unique and plentiful sources to screen novel natural products for combating diseases in man1
  • [1]

    Colwell R R. Microbial biodiversity and biotechnology [A]. In Re2ana2Kudla M E, Wilson E (Eds.), Biodiversity Ⅱ Understandingand Protecting Our Biological Resources [C]. Washington D C:Joseph Henry Press. 1997, 279-287

    [2]

    Fenical W and Jensen P R. Marine microorganisms: a new biomedi2cal resource [A]. In Attaway D H, Zaborsky O R (Eds.), MarineBiotechnology Ⅰ 2Pharmaceutical and Bioactive Natural Products[C].New Y ork: Plenum Press. 1993, 419-457

    [3]

    Jensen P R and Fenical W. Strategies for the discovery of secondarymetabolites from marine bacteria: ecological perspectives [J]. Annu2al Review Microbiology, 1994, 48: 559-584

    [4]

    Fenical W. Chemical studies of marine bacteria: developing a newresource [J]. Chemical Reviews, 1993, 93: 1673-1683

    [5]

    Marderosian A D. Marine pharmaceuticals [J]. Journal of Pharma2ceutical Sciences, 1969, 58: 1-30

    [6]

    Molinski T F. Developments in marine natural products. Receptor-specific bioactive compounds [J].Journal of Natural Products,1993, 56: 1-8

    [7]

    Austin B A. Novel pharmaceutical compounds from marine bacteria[J]. Journal of Applied Bacteriology, 1989, 67: 461-470

    [8]

    Bernan V S, Greenstein M, Maiese WM. Marine microorganisms asa source of new natural products [J]. Advances in Applied Microbiology, 1997, 43: 57-90

    [9]

    Fenical W. Newpharmaceuticalsfrom marine organisms [J]. Trendsin Biotechnology, 1997, 15: 339-341

    [10]

    Feling R H, Buchanan GO, Mincer TJ, et al. Salinosporamide A:a highly cytotoxic proteasome inhibitor from a novel microbial source,a marine bacterium of the new genus Salinospora [J]. AngewandteChemie International Edition English, 2003, 42: 355-357

    [11]

    Mincer TJ,Jensen P R, Kauffman CA, et al. Widespread and persistent populations of a major new marine actinomycete taxon in oceansediments [J]. Applied and Environmental Microbiology, 2002, 68:5005-5011

    [12]

    Rodriguez J C, PuentesJ L F, BazJ P, et al. IB200208, a new cytotoxic polycyclic xanthone produced by a marine2derived Actinomadura Ⅱ. Isolation, physico-chemical properties and structure determination [J]. Journal of Antibiotics, 2003, 56: 318-321

    [13]

    G oodfellow M, Cross T. Classification [A]. In G oodfellow M, Mordarski M, Williams S T (Eds.), The Biology of the Actinomycetes[C]. London: Academic Press. 1984, 7-164

    [14]

    Abraham E P, Chain E, Fletcher CM, et al. Further observationonpenicillin [J]. Lancet, 1941, 2: 177-188

    [15]

    Oskay M, Tamer A Β, Azeri C. Antibacterial activityof some actinomycetes isolated fromfarming soils of Turkey [J]. African Journal of Biotechnology, 2004, 3: 441-446

    [16]

    Heatley N G. A method for the assay of penicillin [J]. BiochemicalJournal, 1944, 38: 61-65

    [17]

    Maskey R P, Li F C, Qin S, et al. Chandrananimycins A2C: Production of novel anticancer antibiotics from a marine Actinomadurasp. Isolate M048 by variationof medium composition and growth conditions [J]. The Journal of Antibiotics, 2003, 56: 622-629

    [18]

    Cui H X, Li F C, Yan B L, et al. Streptomyces sp. M095 fromJiaozhou Bay produces inhibitory-fungal antibiotic, Holomycin [J].Chinese Journal of Marine Drugs, 2006, 25: 11-15

    [19]

    Tang YQ, Sattler I, Thiericke R, et al. Feigrisolides A, B, C andD, new lactones with antibacterial activitiesfrom Streptomyces griseus[J]. Journal of Antibiotics, 2000, 53: 934-943

    [20]

    Tanaka N, Okabe T, Isono F, et al. Lactoquinomycin, a novel anti2cancer antibiotic. I. Taxonomy,isolation, and biological activity[J].Journal of Antibiotics, 1985, 38:1327-1332

计量
  • 文章访问数:  804
  • HTML全文浏览量:  0
  • PDF下载量:  694
  • 被引次数: 0
出版历程
  • 收稿日期:  2006-10-25
  • 修回日期:  2007-05-15
  • 发布日期:  2007-09-24

目录

    /

    返回文章
    返回